AnalysisNews

DERM today

$4.44+$0.02 (+0.45%)close Nov 11, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bearish

1 hourSymmetric Triangle

15 minLeaning Bullish

5 minStrong Bullish

Daily trend turns up above $5.47

Key levels

Resistance$5.05

Resistance$4.70

Support$4.25

Support$3.86

Latest news & SEC filings

AnalystHC Wainwright Reiterates Buy on Journey Medical, Keeps $13 Target

All DERM news →

About Journey Medical

Journey Medical develops, licenses and sells prescription medicines that treat skin conditions, operating mainly in the United States. Its products address rosacea, acne, excessive underarm sweating, fungal skin infections and wound care, and include brands such as Emrosi, Qbrexza, Accutane, Amzeeq and Zilxi. The company markets these treatments to dermatologists and patients through its own sales team. Fortress Biotech holds a voting majority of its stock.

Based on the company's 10-K filed Mar 26, 2026.

Nasdaq · Healthcare

Journey Medical Corp (DERM)

$4.44+0.02 (+0.45%)
WATCHLISTGrade: B+Risk: HIGH
1D5D1M1Y5YMaxSign up for all timeframes
4.785.275.756.244.44Oct 9Oct 19Oct 27Nov 4
High4.56
Low4.38
Open4.43
Volume159K
Avg Vol175K
VWAP4.46
30d High6.72
30d Low4.30
30d Chg-33.93%

What Is the Price Target for DERM?

SEPT Low Target

$13.00

SEPT Mid Target

$13.00

SEPT High Target

$13.00

Analyst Consensus

$13.00

Current: $4.44Upside: +192.8%Confidence: 40%Method: Analyst Consensus

Is DERM a Buy or Sell Right Now?

73
Investability Score
WATCHLIST12-18 months

Thesis

  • •Revenue growing 10.2% YoY with ACCELERATING trend — accelerating momentum.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for DERM.

Start Free Trial →

Is DERM Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B, Analyst Consensus

Fair Value

$10.50

17

Moat Score

NONE

3/9

Piotroski Score

0.4

Altman Z-Score

What Is Smart Money Doing with DERM?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

DERM Growth Story

Revenue YoY

10.2%

3yr Revenue CAGR

-5.7%

EPS Growth YoY

34.72%

FCF Growth YoY

N/A%

Revenue Trend

ACCELERATING

Dark Pool Trades for DERM

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for DERM, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

TimePriceSizeValueSide
20:56:33$4.471,000$$4KSELL
20:49:20$4.461,063$$5KSELL
20:48:18$4.491,000$$4KSELL
20:46:37$4.481,080$$5KMIDPOINT
20:46:37$4.485,000$$22KBUY

5 dark pool trades shown · $$41K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Journey Medical Corp (DERM) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

DERM — frequently asked questions

What is DERM stock price today?

Journey Medical Corp (DERM) is at $4.44, up 0.45% (+$0.02) at the Nov 11, 2026 close.

Why is DERM stock moving today?

Latest DERM news — Oct 26, 2026: HC Wainwright Reiterates Buy on Journey Medical, Keeps $13 Target

What is the DERM price target?

The average analyst price target for DERM is $13.00, ranging from $13 to $13, based on 1 analysts.

What do analysts rate DERM?

Analyst ratings for DERM: 0 Buy, 3 Hold, 0 Sell — consensus Hold.

Did DERM beat earnings?

DERM last reported on Aug 12, 2026: EPS -$0.01 vs -$0.02 expected — a beat of 55.6%.

Does DERM pay a dividend?

DERM does not currently pay a dividend.

How much debt does DERM have?

Journey Medical Corp reported $25M of debt and $26M of cash (Jun 30, 2026).

What are DERM support and resistance levels?

Support: $4.25, $3.86, $3.20. Resistance: $4.70, $5.05, $5.47.

What are insiders doing with DERM?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on DERM?

Oct 26, 2026: HC Wainwright Reiterates Buy on Journey Medical, Keeps $13 Target